GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, PPARA |
9.95193 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.70274 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.62842 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, AKR1B10, ALPL, AOX1, APP, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, TYR, XDH |
8.01937 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADORA2A, AKR1B1, ALPL, APP, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, KIT, MMP2, MMP9, PPARA, RORC, TERT, TYR |
7.6204 |
[BP] GO:0010033 |
response to organic substance
|
ADORA2A, AKR1B1, ALPL, APP, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, KIT, MMP2, PPARA, RORC, TYR |
7.49293 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, MMP2, MMP9, PPARA, RORC, TYR |
7.30127 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADORA2A, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.07849 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, AKR1B1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, F3, FABP3, FLT3, KIT, MMP12, MMP2, MMP9, TERT, XDH |
7.00466 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, RORC, TYR |
7.00466 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ADORA2A, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, HSD11B2, RORC, TYR |
7.00466 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADORA2A, ADRB1, AKR1B1, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F3, FLT3, HCAR2, KIT, MMP12, MMP9, PTPN1, TERT, TNKS, TNKS2, XDH |
7.00466 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADORA2A, ADRB1, AKR1B1, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F3, FLT3, HCAR2, KIT, MMP12, MMP9, PTPN1, TERT, TNKS, TNKS2, XDH |
7.0042 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.0042 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, KIT, MMP2, PPARA |
6.86136 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, CDK6, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, PPARA, TERT, TNKS, TNKS2, XDH |
6.82571 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.47298 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HCAR2, KIT, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
6.12722 |
[BP] GO:0044281 |
small molecule metabolic process
|
ADORA2A, AKR1B1, AKR1B10, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, GBA2, PPARA, TYR, XDH |
6.02773 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, ALPL, APP, BCL2, CA2, CA9, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, KIT, MMP2, MMP9, PPARA, RORC, TERT, TNKS2, TYR |
6.0276 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.93646 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, KIT, PPARA |
5.89594 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, KIT, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
5.80773 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KIT, PPARA, TYR |
5.71088 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.45389 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALPL, APP, BCL2, CA2, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KIT, MMP9, PPARA, RORC, TYR |
5.38073 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KIT, MMP9, TERT |
4.96084 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, BACE1, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, HCAR2, KIT, MMP12, MMP9, PTPN1, TERT, TNKS, TNKS2, XDH |
4.96084 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALPL, AOX1, APP, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, TYR, XDH |
4.93299 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADORA2A, ADRB1, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, F3, FLT3, KIT, MMP12, MMP9, PTPN1, TERT, TNKS, TNKS2, XDH |
4.90986 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, ADORA2A, AKR1B1, AKR1B10, ALPL, AOX1, APP, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, KIT, MMP1, MMP2, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, TYR, XDH |
4.88647 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, BACE1, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, HCAR2, KIT, MMP12, MMP9, PTPN1, TERT, TNKS, TNKS2, XDH |
4.87427 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.7537 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, FABP3, FABP4, FUT7, GBA2, KIT, PPARA |
4.75272 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.66532 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, KIT, MMP9, TERT |
4.58338 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, KIT, MMP12, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
4.47813 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, ESR1, F3, FLT3, KIT, MMP12, MMP2, MMP9, TERT |
4.44894 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADORA2A, ADRB1, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESRRA, F3, FABP4, FLT3, KIT, MMP12, MMP2, MMP9, PTPN1, TERT, TNKS, TNKS2, XDH |
4.40217 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.39996 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, FABP4, FLT3, KIT, MMP2, MMP9, RORC, TERT |
4.39996 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.34812 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALPL, AOX1, APP, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, TYR, XDH |
4.28416 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, AKR1B1, ALPL, APP, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, KIT, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TERT, TYR |
4.21871 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, KIT, MMP12, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
4.19415 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, KIT, MMP12, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
4.10784 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADORA2A, BCL2, CA2, CA7, CACNA1C, CDK6, EGFR, HCAR2, TNKS, TNKS2 |
4.01835 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, EGFR, KIT |
3.82612 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7, EGFR, KIT |
3.82612 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, XDH |
3.72641 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADORA2A, ADRB1, AKR1B1, AKR1B10, ALPL, APP, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, KIT, MMP1, MMP12, MMP2, MMP9, PPARA, RORC, TNKS2, TYR |
3.69693 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA2A, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F3, KIT, MMP9, TERT |
3.69693 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CACNA1C, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F3, KIT, MMP9, TERT |
3.68543 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.64008 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, APP, BCL2, CA2, CA7, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F3, HCAR2, KIT, MMP12, MMP9, PPARA, PTPN1, TERT |
3.64008 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.64008 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, KIT, MMP9, TERT |
3.57099 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.57099 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, BCL2, CDK6, CYP1A1, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, FABP4, FLT3, KIT, MMP2, RORC |
3.56502 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.54285 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.54285 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FLT3, KIT, MMP9, PTPN1, XDH |
3.40544 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FLT3, KIT, MMP9, PTPN1, XDH |
3.40544 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, EGFR, ERBB2, PPARA |
3.37882 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F3, KIT, MMP9, TERT |
3.37378 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADORA2A, ADRB1, AKR1B1, APP, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, KIT, MMP12, MMP2, MMP9, PPARA, PTPN1, TERT, TNKS, TNKS2, XDH |
3.31718 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.27479 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, ADORA2A, APP, CDK6, CYP19A1, DYRK1A, EGFR, ESR1, F3, FABP4, MMP12, MMP2, PPARA, PTPN1, TERT, XDH |
3.27479 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADORA2A, APP, CA2, CA7, EGFR |
3.25299 |
[BP] GO:0048143 |
None
|
ADORA2A, APP, EGFR |
3.24118 |
[BP] GO:0001973 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.24118 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, APP, BCL2, CA2, CYP1A1, EGFR, HSD11B2, KIT, MMP2, PPARA, TERT, TYR |
3.22217 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.17701 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADORA2A, CA2, CA7 |
3.1651 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, KIT, MMP12, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
3.16318 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, DYRK1A, EGFR, ESR1, KIT, PPARA, RORC |
3.15646 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.12708 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.12708 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.12708 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
3.05586 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.00741 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, ADRB1, APP, BCL2, CDC25B, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, KIT, MMP9, PTPN1, TERT, TNKS, XDH |
2.95793 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, TYR |
2.91578 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, ADORA2A, CA2, CA7 |
2.91578 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, AKR1B1, APP, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HCAR2, KIT, MMP12, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
2.90047 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APP, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, KIT, MMP12, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
2.89531 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
ADORA2A, CA2, CA7, EGFR, HCAR2, TNKS, TNKS2 |
2.84984 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.82068 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.81087 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADORA2A, CA2, CA7 |
2.81087 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, BCL2, CA2, CYP19A1, EGFR, ERBB2, HCAR2, MMP12, TERT |
2.78178 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.7734 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, KIT, MMP9, PPARA, PTPN1, TERT, XDH |
2.75236 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, BCL2, CYP1B1, EGFR, ERBB2, F3, FLT3, KIT, PTPN1, XDH |
2.74309 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, FABP4, FLT3, KIT, MMP2, MMP9, PTPN1, RORC, TERT |
2.71617 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADORA2A, ADRB1, ALPL, APP, BCL2, CDC25B, CDK6, CYP1A1, EGFR, ERBB2, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, KIT, MMP2, MMP9, RORC, TERT |
2.70873 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.70806 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, APP, BCL2, CDK6, CYP1B1, ERBB2, FABP3, TERT, XDH |
2.68762 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADORA2A, BCL2, CDK6, CYP19A1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, MMP12, MMP9, PPARA, PTPN1, TERT, XDH |
2.68723 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA2A, ADORA3, ADRB1, APP, BCL2, CA2, CACNA1C, CDK6, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F3, HCAR2, KIT, MMP12, MMP9, TERT, TNKS2, XDH |
2.68723 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, BCL2, CA2, CA7, CACNA1C, CYP19A1, EGFR, ERBB2, HCAR2, MMP12, MMP9, PPARA, PTPN1, TERT |
2.67008 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.67008 |
[BP] GO:0003014 |
None
|
ADORA1, ADORA2A, AKR1B1, BCL2, HSD11B2 |
2.66758 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.64869 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.62813 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, RORC |
2.62813 |
[BP] GO:1901184 |
None
|
ADORA1, APP, EGFR, ERBB2, MMP9 |
2.61453 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.59919 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.59919 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, KIT, MMP9, PTPN1, TERT, XDH |
2.5965 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, TERT |
2.5661 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.5661 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, KIT, MMP2, MMP9 |
2.56551 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, APP, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, F3, FABP4, FLT3, KIT, MMP9, PTPN1, TERT, TNKS, XDH |
2.5594 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, FLT3, TERT |
2.55609 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ADORA2A, AKR1B1, BCL2, CA9, CDK6, CYP1A1, CYP1B1, EGFR, FABP3, HSD11B2 |
2.55594 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HCAR2, KIT, PPARA, RORC |
2.55474 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
ADORA2A, ADRB1, APP, DNMT1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, MMP12, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2 |
2.55327 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.55184 |
[BP] GO:0006690 |
icosanoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.5475 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, MMP1, MMP12, MMP2, MMP9 |
2.51685 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, KIT, MMP9, PPARA, PTPN1, XDH |
2.51685 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, TERT |
2.51685 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA2A, ADORA3, ADRB1, AKR1B1, APP, BCL2, CA1, CA2, CACNA1C, CDK6, CSNK2A1, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, KIT, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS, TNKS2 |
2.51261 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.50373 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.48981 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, ADRB1, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, KIT, MMP9, PPARA, PTPN1, XDH |
2.48546 |
[BP] GO:0010243 |
response to organonitrogen compound
|
ADORA2A, AKR1B1, APP, DNMT1, EGFR, FABP3, FLT3, HSD11B2, MMP2, PPARA, TYR |
2.45971 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.42295 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.42295 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F3, KIT, MMP9, TERT |
2.415 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9 |
2.40377 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, RORC |
2.40377 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRB1, APP, BCL2, CDC25B, EGFR, ERBB2, ESR1, F3, FLT3, KIT, PTPN1, TERT, TNKS, XDH |
2.39841 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.38632 |
[BP] GO:0007423 |
None
|
BCL2, CACNA1C, CYP1A1, EGFR, KIT |
2.37943 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, F3, FLT3, KIT, MMP9, PTPN1, XDH |
2.35088 |
[BP] GO:0034502 |
protein localization to chromosome
|
ESR1, TERT, TNKS, TNKS2 |
2.3476 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, KIT |
2.34557 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, TERT |
2.33766 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, F3, FLT3, KIT, MMP9, PTPN1, XDH |
2.32734 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, BCL2, CYP1A1, EGFR, ERBB2, ESR1, FLT3, KIT, TYR |
2.32734 |
[BP] GO:0006631 |
fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
2.2999 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR |
2.29934 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, ADORA2A, AKR1B1, ALPL, AOX1, APP, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DYRK1A, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, GBA2, KIT, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, TNKS, TNKS2, TYR, XDH |
2.29917 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.28528 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADORA2A, APP, CA2, CACNA1C, EGFR, ERBB2, HCAR2, MMP12, PTPN1 |
2.2623 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.26163 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.25804 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.23657 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, ADORA2A, BCL2, CA2, CA7, CACNA1C |
2.23307 |
[BP] GO:1901698 |
response to nitrogen compound
|
ADORA2A, AKR1B1, APP, DNMT1, EGFR, FABP3, FLT3, HSD11B2, MMP2, PPARA, TYR |
2.23002 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.21968 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
2.21968 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.20076 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.20076 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.20076 |
[BP] GO:0061900 |
None
|
ADORA2A, APP, EGFR |
2.20076 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.20076 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FLT3, KIT, MMP9, PTPN1, XDH |
2.19043 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
ADRB1, APP, BCL2, TNKS2 |
2.19043 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP4, FLT3, KIT, MMP9, PPARA, PTPN1, XDH |
2.19043 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.19043 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, MMP9, PTPN1, TERT, XDH |
2.19043 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA2A, ADORA3, ADRB1, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, F3, FABP4, FLT3, KIT, MMP9, PPARA, PTPN1, TERT, TNKS, XDH |
2.19043 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADORA2A, ADRB1, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, KIT, MMP12, MMP9, PTPN1, TERT, TNKS, TNKS2, XDH |
2.18308 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2 |
2.1463 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ADORA2A, APP, BCL2, CA2, CDK6, CYP19A1, ERBB2, ESR1, ESRRA, HCAR2, KIT, MMP12, MMP2, PTPN1 |
2.1259 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, F3, FLT3, KIT, MMP9, PTPN1, XDH |
2.11822 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, APP, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, KIT, MMP12, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
2.09871 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2 |
2.09025 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.06617 |
[BP] GO:1901360 |
None
|
ACHE, ADORA2A, AKR1B1, AKR1B10, AOX1, APP, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ERBB2, ESR1, ESR2, ESRRA, ESRRB, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PPARA, RORC, TERT, TYR, XDH |
2.06103 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADORA2A, APP, BCL2, CACNA1C, CSNK2A1, EGFR, ERBB2, HCAR2, MMP12, PTPN1, TERT |
2.05868 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, BACE1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GBA2, XDH |
2.05666 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, KIT, PTPN1 |
2.03806 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.03511 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CSNK2A1, DNMT1, DYRK1A, EGFR, ESR1, ESR2, ESRRA, FABP4, HCAR2, MMP12, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, XDH |
2.0299 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.0299 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.0299 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.0299 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, BCL2, CDC25B, DNMT1, DYRK1A, EGFR, ERBB2, FLT3, KIT, MMP9, PTPN1, XDH |
2.0278 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, AKR1B1, APP, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, HSD11B2, KIT, MMP2, MMP9, PPARA, PTPN1, TERT |
2.00646 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.00014 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1 |
3.28993 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2 |
2.43422 |
[CC] GO:0099056 |
None
|
ADORA1, ADORA2A |
2.42295 |
[CC] GO:0098889 |
None
|
ADORA1, ADORA2A |
2.42295 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, GBA2, HSD11B1, HSD11B2, HSD17B2 |
2.42168 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ADRB1, ALPL, APP, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, KIT, MMP2, PTPN1, TERT, TNKS, TNKS2, TYR |
2.30447 |
[MF] GO:0046914 |
transition metal ion binding
|
AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
15.4026 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.94602 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MMP1, MMP12, MMP2, MMP9, PTPN1, TERT, TNKS, TNKS2, TYR, XDH |
8.94489 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALPL, AOX1, APP, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, KIT, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, TYR, XDH |
8.39533 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS |
7.95723 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.73306 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.39367 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALPL, AOX1, APP, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, KIT, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, TYR, XDH |
6.2606 |
[MF] GO:0046872 |
metal ion binding
|
ALPL, AOX1, APP, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, KIT, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TERT, TNKS, TNKS2, TYR, XDH |
5.92236 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.57624 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.38073 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.27331 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.23696 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.23696 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
5.23696 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.20423 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.96084 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.83366 |
[MF] GO:0005506 |
iron ion binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
4.75272 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.9831 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
3.71028 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.54285 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.39309 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.31379 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.28993 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.28141 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KIT |
3.24118 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B2, HSD17B1, XDH |
3.20096 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.154 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.08527 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, KIT, PPARA, RORC |
3.02628 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.99659 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, CDK6, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, KIT, PPARA, RORC |
2.8493 |
[MF] GO:0008289 |
lipid binding
|
ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC |
2.80386 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADORA2A, AOX1, APP, BCL2, CSNK2A1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, FLT3, KIT, MMP9, TERT, TYR, XDH |
2.78121 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.7734 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.7734 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.7734 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.71617 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, KIT, PPARA, RORC |
2.51875 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.48941 |
[MF] GO:0019899 |
enzyme binding
|
ADORA2A, ADRB1, APP, BACE1, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, EGFR, ERBB2, ESR1, ESR2, ESRRB, F3, KIT, PPARA, PTPN1, TNKS2 |
2.38729 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.38632 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, ERBB2, FLT3, KIT |
2.28509 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.20076 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.16247 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA2A, ADORA3, ADRB1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, KIT, PPARA, RORC |
2.13709 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.0299 |